Current concepts in thrombotic thrombocytopenic purpura

被引:69
作者
Tsai, HM [1 ]
机构
[1] Albert Einstein Coll Med, Div Hematol, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Bronx, NY 10467 USA
来源
ANNUAL REVIEW OF MEDICINE | 2006年 / 57卷
关键词
von Willebrand factor; ADAMTS13; shear stress; hemolytic uremic syndrome;
D O I
10.1146/annurev.med.57.061804.084505
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Recent advances have demonstrated that thrombotic thrombocytopenic purpura (TTP), characterized by widespread thrombosis in the arterioles and capillaries, is caused by deficiency of a circulating zinc metalloprotease, ADAMTS13. Two types of TTP are recognized: autoimmune TTP, caused by inhibitory antibodies of ADAMTS13, and hereditary TTP, caused by genetic mutations of ADAMTS13. This article reviews the characteristics and function of ADAMTS13, the mechanism by which ADAMTS13 deficiency may lead to thrombosis, and the causes of ADAMTS13 deficiency. It also discusses how the new knowledge may improve the diagnosis and treatment of this previously mysterious disorder.
引用
收藏
页码:419 / 436
页数:20
相关论文
共 75 条
[1]   A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family [J].
Apte, SS .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (06) :981-985
[2]  
Arai S, 2001, Hematol J, V2, P292, DOI 10.1038/sj.thj.6200127
[3]   IMMUNOHISTOCHEMISTRY OF VASCULAR LESION IN THROMBOTIC THROMBOCYTOPENIC PURPURA, WITH SPECIAL REFERENCE TO FACTOR-VIII RELATED ANTIGEN [J].
ASADA, Y ;
SUMIYOSHI, A ;
HAYASHI, T ;
SUZUMIYA, J ;
KAKETANI, K .
THROMBOSIS RESEARCH, 1985, 38 (05) :469-479
[4]  
Bell WR, 1997, SEMIN HEMATOL, V34, P134
[5]   Thrombotic thrombocytopenic purpura associated with ticlopidine - A review of 60 cases [J].
Bennett, CL ;
Weinberg, PD ;
Rozenberg-Ben-Dror, K ;
Yarnold, PR ;
Kwaan, HC ;
Green, D .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (07) :541-544
[6]   Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders:: a severely deficient activity is specific for thrombotic thrombocytopenic purpura [J].
Bianchi, V ;
Robles, R ;
Alberio, L ;
Furlan, M ;
Lämmle, B .
BLOOD, 2002, 100 (02) :710-713
[7]   THERAPY OF THROMBOTIC THROMBOCYTOPENIC PURPURA - AN OVERVIEW [J].
BUKOWSKI, RM ;
HEWLETT, JS ;
REIMER, RR ;
GROPPE, CW ;
WEICK, JK ;
LIVINGSTON, RB .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1981, 7 (01) :1-8
[8]   EFFECTIVENESS OF THE CRYOSUPERNATANT FRACTION OF PLASMA IN THE TREATMENT OF REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA [J].
BYRNES, JJ ;
MOAKE, JL ;
KLUG, P ;
PERIMAN, P .
AMERICAN JOURNAL OF HEMATOLOGY, 1990, 34 (03) :169-174
[9]   Proteolytic inactivation of ADAMTS13 by thrombin and plasmin [J].
Crawley, JTB ;
Lam, JK ;
Rance, JB ;
Mollica, LR ;
O'Donnell, JS ;
Lane, DA .
BLOOD, 2005, 105 (03) :1085-1093
[10]   Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver [J].
Daly, AS ;
Hasegawa, WS ;
Lipton, JH ;
Messner, HA ;
Kiss, TL .
TRANSFUSION AND APHERESIS SCIENCE, 2002, 27 (01) :3-12